Skip to main content

Impact of HLA Matching and HLA Antibodies in Organ Transplantation: A Collaborative Transplant Study View

  • Protocol
  • First Online:
Immunogenetics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 882))

Abstract

The Collaborative Transplant Study (CTS) was initiated in 1982 in Heidelberg, Germany, and originated from the need to gain further insight into the complex problems and risks involved in human organ transplantation. Currently, more than 400 transplant centers in 45 countries are contributing to this voluntary international effort, and from the beginning of the study, the impact on graft outcome of immunological factors, such as matching for HLA antigens and allosensitization to HLA and non-HLA antigens, have been areas of interest. Herein, we summarize the recent findings from the CTS on these two topics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mange KC et al (2001) A comparison of the survival of shipped and locally transplanted cadaveric renal allografts. N Engl J Med 345:1237–1242

    Article  PubMed  CAS  Google Scholar 

  2. Collaborative Transplant Study, University of Heidelberg, Germany, Website. www.ctstransplant.org. Accessed 29 Nov 2010

  3. Opelz G, Döhler B (2007) Multicenter analysis of kidney preservation. Transplantation 83:247–253

    Article  PubMed  Google Scholar 

  4. Opelz G, Döhler B (2007) Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 84:137–143

    Article  PubMed  CAS  Google Scholar 

  5. Opelz G, Döhler B (2010) Impact of HLA mismatching on incidence of posttransplant non-Hodgkin lymphoma after kidney transplantation. Transplantation 89:567–572

    Article  PubMed  CAS  Google Scholar 

  6. Opelz G, Döhler B (2010) Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. Transplantation 91:65–69

    Article  Google Scholar 

  7. Meier-Kriesche HU et al (2009) A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 88:23–29

    Article  PubMed  Google Scholar 

  8. Opelz G et al (2010) Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report. Transplantation 90:912–927

    Article  PubMed  CAS  Google Scholar 

  9. Opelz G, Döhler B (2010) Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation 90:292–297

    Article  PubMed  Google Scholar 

  10. Nikkel LE et al (2009) Risk of fractures after renal transplantation in the United States. Transplantation 87:1846–1851

    Article  PubMed  Google Scholar 

  11. O’Shaughnessy EA et al (2002) Risk factors for fractures in kidney transplantation. Transplantation 74:362–366

    Article  PubMed  Google Scholar 

  12. Vautour LM et al (2004) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15:160–167

    Article  PubMed  Google Scholar 

  13. Patel S et al (2001) Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 16:1863–1870

    Article  PubMed  CAS  Google Scholar 

  14. Opelz G et al (1999) HLA compatibility and organ transplant survival. Collaborative Trans-plant Study. Rev Immunogenet 1:334–342

    PubMed  CAS  Google Scholar 

  15. Süsal C, Pelzl S, Opelz G (2003) Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30. Transplantation 76:1231–1232

    Article  PubMed  Google Scholar 

  16. Süsal C, Döhler B, Opelz G (2009) Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 70:569–573

    Article  PubMed  Google Scholar 

  17. Opelz G et al (1981) Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation 32:177–183

    Article  PubMed  CAS  Google Scholar 

  18. El-Awar N et al (2002) Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. Transplant Proc 34:2531–2532

    Article  PubMed  CAS  Google Scholar 

  19. Opelz G, Collaborative Transplant Study (2005) Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365:1570–1576

    Article  PubMed  CAS  Google Scholar 

  20. Zou Y et al (2006) Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 67:230–237

    Article  PubMed  CAS  Google Scholar 

  21. Terasaki PI, Ozawa M (2005) Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 80:1194–1197

    Article  PubMed  CAS  Google Scholar 

  22. Breimer ME et al (2009) Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 87:549–556

    Article  PubMed  CAS  Google Scholar 

  23. Reinsmoen NL et al (2010) Anti-angiotensin type 1 receptor antibodies associated with ­antibody mediated rejection in donor HLA antibody negative patients. Transplantation 90:1473–1477

    Article  PubMed  CAS  Google Scholar 

  24. Morath C et al (2010) An integrative approach for the transplantation of high-risk sensitized patients. Transplantation 90:645–653

    Article  PubMed  Google Scholar 

  25. Fuggle SV, Martin S (2008) Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation 86:384–390

    Article  PubMed  CAS  Google Scholar 

  26. Süsal C, Döhler B, Opelz G (2009) Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 70:569–573

    Article  PubMed  Google Scholar 

  27. Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735–739

    Article  PubMed  CAS  Google Scholar 

  28. Opelz G, Döhler B, Süsal C (2009) Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Hum Immunol 70:627–630

    Article  PubMed  Google Scholar 

  29. Bingaman AW et al (2008) A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 86:1864–1868

    Article  PubMed  Google Scholar 

  30. Ettenger RB et al (1979) Long-term cadaver allograft survival in the recipient with a positive B lymphocyte crossmatch. Transplantation 27:315–318

    Article  PubMed  CAS  Google Scholar 

  31. Hourmant M et al (1990) Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one center study. Clin Transpl 301–309

    Google Scholar 

  32. Bryan CF et al (2007) Renal graft survival is not influenced by a positive flow B-cell crossmatch. Clin Transpl 21:72–79

    Article  Google Scholar 

  33. Magee CC et al (2008) Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center’s experience. Transplantation 86:96–103

    Article  PubMed  Google Scholar 

  34. Kerman RH et al (1990) Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients. Transplantation 49:52–56

    Article  PubMed  CAS  Google Scholar 

  35. Christiaans MH et al (1996) No advantage of flow cytometry crossmatch over complement dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 62:1341–1347

    Article  PubMed  CAS  Google Scholar 

  36. Swinnen LJ et al (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723–1728

    Article  PubMed  CAS  Google Scholar 

  37. Opelz G, Henderson R (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514–1516

    Article  PubMed  CAS  Google Scholar 

  38. Opelz G, Döhler B (2004) Lymphomas after solid organ transplantation: a Collaborative Transplant Study report. Am J Transplant 24:222–230

    Article  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge the generous support of the staff members at participating CTS centers.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Caner Süsal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Süsal, C., Opelz, G. (2012). Impact of HLA Matching and HLA Antibodies in Organ Transplantation: A Collaborative Transplant Study View. In: Christiansen, F., Tait, B. (eds) Immunogenetics. Methods in Molecular Biology, vol 882. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-842-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-842-9_15

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-841-2

  • Online ISBN: 978-1-61779-842-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics